VNDA
Vanda Pharmaceuticals Inc
Price:  
4.42 
USD
Volume:  
1,978,032.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

VNDA EV/EBITDA

-40.4%
Upside

As of 2025-02-18, the EV/EBITDA ratio of Vanda Pharmaceuticals Inc (VNDA) is -37.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. VNDA's latest enterprise value is 157.23 mil USD. VNDA's TTM EBITDA according to its financial statements is -4.20 mil USD. Dividing these 2 quantities gives us the above VNDA EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 11.9x - 15.5x 13.8x
Forward P/E multiples 17.1x - 22.4x 20.2x
Fair Price 0.86 - 4.85 2.63
Upside -80.5% - 9.8% -40.4%
4.42 USD
Stock Price
2.63 USD
Fair Price

VNDA EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-14 -37.39
2025-02-13 -41.27
2025-02-12 -41.97
2025-02-11 -41.55
2025-02-10 -40.17
2025-02-07 -42.66
2025-02-06 -41.14
2025-02-05 -38.92
2025-02-04 -38.22
2025-02-03 -35.87
2025-01-31 -37.25
2025-01-30 -39.61
2025-01-29 -38.92
2025-01-28 -37.67
2025-01-27 -37.81
2025-01-24 -37.11
2025-01-23 -37.39
2025-01-22 -36.42
2025-01-21 -38.64
2025-01-17 -36.56
2025-01-16 -37.67
2025-01-15 -37.81
2025-01-14 -36.84
2025-01-13 -38.92
2025-01-10 -39.89
2025-01-08 -40.58
2025-01-07 -43.35
2025-01-06 -42.52
2025-01-03 -43.35
2025-01-02 -42.94
2024-12-31 -42.52
2024-12-30 -42.38
2024-12-27 -42.80
2024-12-26 -42.80
2024-12-24 -43.08
2024-12-23 -41.00
2024-12-20 -42.38
2024-12-19 -40.30
2024-12-18 -39.19
2024-12-17 -41.69
2024-12-16 -40.30
2024-12-13 -40.03
2024-12-12 -40.17
2024-12-11 -40.86
2024-12-10 -39.89
2024-12-09 -42.94
2024-12-06 -43.22
2024-12-05 -42.38
2024-12-04 -43.22
2024-12-03 -44.19